🇺🇸 FDA
Patent

US 9717716

Methods of sedation during critical care treatment

granted A61KA61K31/437A61K9/0019

Quick answer

US patent 9717716 (Methods of sedation during critical care treatment) held by OVID THERAPEUTICS INC. expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
OVID THERAPEUTICS INC.
Grant date
Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/437, A61K9/0019